Publications by authors named "Kowser Miah"

Claim this Profile
A
A quantitative model-based approach for adavosertib dose selection in patients with uterine serous carcinoma.
Shankar Lanke, Kowser Miah, Damilola Olabode, Jincheng Yang, Srinivas Bachina

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain exposure of the mesenchymal-epithelial transition inhibitor savolitinib in nonhuman primates: A positron emission tomography study.
Peter Johnström, Zsolt Cselényi, Kowser Miah, Aurelija Jucaite, Graeme Scarfe

J Pharmacol Exp Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label, Multicenter, Phase I Study to Assess Safety and Tolerability of Adavosertib Plus Durvalumab in Patients with Advanced Solid Tumors.
Manish R Patel, Gerald S Falchook, Judy S Wang, Esteban Rodrigo Imedio, Sanjeev Kumar, Kowser Miah

Target Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic Modeling of Adavosertib (AZD1775) in Patients with Solid Tumors.
Martin Johnson, Daniel Kaschek, Dana Ghiorghiu, Shankar Lanke, Kowser Miah

J Clin Pharmacol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART Trial.
Susanne A Gatz, Anne C Harttrampf, Caroline Brard, Francisco Bautista, Nicolas André, Kowser Miah

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study to Evaluate Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of Savolitinib in Healthy Male Volunteers.
Kowser Miah, Karthick Vishwanathan, Graeme Scarfe, Yan Li, Indira Hara

Clin Pharmacol Drug Dev· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination With Tremelimumab or Danvatirsen in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Vincent Ribrag, Seung Tae Lee, David Rizzieri, Martin J S Dyer, Luis Fayad, Kowser Miah

Clin Lymphoma Myeloma Leuk· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis